SSPs issued for Fluoxetine 30mg caps & Salazopyrin EN-Tabs 500mg: Urgent actions required by pharmacy teams

SSPs issued for Fluoxetine 30mg caps & Salazopyrin EN-Tabs 500mg: Urgent actions required by pharmacy teams

October 21, 2020

In response to significant ongoing disruption to the supply of Fluoxetine 30mg capsules and Salazopyrin® EN-Tabs 500mg, two Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC).

Introduced with immediate effect today, Tuesday 20th October 2020, SSP07 has been developed by clinicians and provides pharmacists with procedures to follow in providing a suitable alternative product(s), three Fluoxetine 10mg capsules or one Fluoxetine 20mg capsule and one Fluoxetine 10mg capsule, in response to the serious shortage affecting Fluoxetine 30 mg capsules.

SSP08 has been developed by clinicians and provides pharmacists with procedures to follow in providing a suitable alternative product, generic Sulfasalazine 500mg gastro-resistant (GR) tablets in response to the serious shortage affecting Salazopyrin® EN-Tabs 500mg. Both SSPs have been authorised by the Secretary of State to help manage the supply of these products and to try to ensure that fewer patients need to return to their prescriber for an alternative.

All community pharmacy teams will receive an email to their shared NHSmail account informing them of these SSPs. Community pharmacy contractors and their teams are asked to read the documents below in full and to implement the protocols with immediate effect on Tuesday 20th October 2020.

SSP07: Fluoxetine 30mg capsules
SSP07 may be amended or revoked at any time but currently expires on Tuesday 22nd December 2020 – PSNC will update contractors on any changes.

SSP08: Salazopyrin® EN-Tabs 500mg
SSP08 may be amended or revoked at any time but currently expires on Friday 4th December 2020 – PSNC will update contractors on any changes.

Medicine supply notifications have also been issued for Fluoxetine 30mg capsules and Salazapyrin En-Tabs 500mg tablets

Further details below.


SSP07 recommendations

The SSP provides that three Fluoxetine 10mg capsules or one Fluoxetine 20mg capsule and one Fluoxetine 10mg capsule may be supplied against prescriptions for Fluoxetine 30mg capsules as follows:

For prescriptions (NHS or private) requesting: Supply permitted under SSP06:
Fluoxetine 30mg capsules

3 x Fluoxetine 10mg capsules

OR

1 x Fluoxetine 20mg capsule and 1 x Fluoxetine 10mg capsule

SSP08 recommendations

The SSP provides that generic Sulfasalazine 500mg gastro-resistant (GR) tablets may be supplied against prescriptions for Salazopyrin® EN-Tabs 500mg :

For prescriptions (NHS or private) requesting: Supply permitted under SSP06:
Salazopyrin® EN-Tabs 500mg Generic Sulfasalazine 500mg gastro-resistant (GR) tablets

The pharmacist must exercise their professional judgement to ensure the alternative product is suitable for the patient.

Reimbursement

Reimbursement is for the medicine supplied in accordance with the SSP and not the originally prescribed medicine i.e. in this instance contractors will be reimbursed the Drug Tariff Part VIIIA reimbursement price for the Fluoxetine 20mg capsules, Fluoxetine 10mg capsules or Sulfasalazine 500mg gastro-resistant (GR) tablets (or any concessionary price granted, where applicable). The reimbursement price will account for VAT payment. Supply in accordance with the SSP will result in the following fees being paid to the contractor:

  • One Single Activity fee (currently £1.27)
  • One SSP fee (£5.35)

Support in implementing the SSPs

The following resources have been developed to support pharmacy teams in using these protocols.

PSNC Briefing 036/20: Serious Shortage Protocol (SSP): SSP07 – Fluoxetine 30mg capsules

PSNC Briefing 037/20: Serious Shortage Protocol (SSP): SSP08 – Salazopyrin® EN-Tabs 500mg

Current versions of SSPs

Serious Shortage Protocols Operational Guidance

Serious Shortage Protocols Questions & Answers

PSNC’s Serious Shortage Protocols (SSPs) Endorsing Factsheet

PSNC Briefing 023/19: Serious Shortage Protocols – A guide for community pharmacy teams

Background information on SSPs

Further information on what SSPs are and when they may be used is available via the links below.

Serious Shortage Protocols (SSPs) on-demand webinar

Serious Shortage Protocols (SSPs) webpage

 



Posted in: , , ,


More Latest News >